Cargando…
Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology
BACKGROUND: The cannabinoid-1 receptor blockers have been proposed in the management of obesity and obesity-related liver diseases (fatty liver as NAFLD or NASH). Due to increasing number of patients to be potentially treated and the need to assess the advantage of this treatment in terms of risk/be...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763866/ https://www.ncbi.nlm.nih.gov/pubmed/19818116 http://dx.doi.org/10.1186/1471-230X-9-75 |